FDA Clarifies Enforcement Policy Around Communications of Scientific Information on Unapproved Uses of Drugs and Medical Devices (JSON)

lexblog.com/lib/2RVCWQY1view recordjson

{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "FDA Clarifies Enforcement Policy Around Communications of Scientific Information on Unapproved Uses of Drugs and Medical Devices",
    "url": "https://www.lexblog.com/2025/01/30/fda-clarifies-enforcement-policy-around-communications-of-scientific-information-on-unapproved-uses-of-drugs-and-medical-devices-2/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-2RVCWQY1",
        "url": "https://www.lexblog.com/lib/2RVCWQY1/"
    },
    "datePublished": "2025-01-30T17:23:04-05:00",
    "dateModified": "2026-02-02T14:00:23-05:00",
    "author": {
        "@type": "Person",
        "name": "Linda Malek, Jason Johnson, Michelle Chipetine"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Crowell & Moring LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Health Law",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.crowellhealthsolutionsblog.com/?p=2264",
    "sourceStability": "may-move"
}